Medicover AB (publ) (MCOV-B.ST) Research

Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.

Market snapshot

Symbol
MCOV-B.ST
Price
$206
Day change
-4.19%
Market cap
$2.8B
P/E ratio
35.33x
52-week range
179.4-295
Sector
Healthcare
Industry
Medical - Care Facilities
Next earnings
in 1 month

Peer companies

  • AddLife AB (publ) (ALIF-B.ST)
  • Ambea AB (publ) (AMBEA.ST)
  • Asker Healthcare Group AB (ASKER.ST)
  • Attendo AB (publ) (ATT.ST)
  • BioArctic AB (publ) (BIOA-B.ST)
  • Camurus AB (publ) (CAMX.ST)
  • Elekta AB (publ) (EKTA-B.ST)
  • Sectra AB (publ) (SECT-B.ST)

Open Medicover AB (publ) (MCOV-B.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.